Acoustic and photoacoustic molecular imaging of cancer

Journal of Nuclear Medicine

Volumn 54, Issue 11, 2013, Pages 1851-1854

  Wilson, Katheryne E ^a   Wang, Tzu Yin ^a   Willmann, Jürgen K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Microbubble; Molecular imaging; Nanodroplet; Nanoparticle; Photoacoustic imaging; Ultrasound

Indexed keywords

ALPHA5BETA3 INTEGRIN RECEPTOR; CONTRAST MEDIUM; DIFFERENTIATION ANTIGEN; ELECTRON EXCITED STATE METHYLENE BLUE; GOLD NANOPARTICLE; INTEGRIN RECEPTOR; MATRIX METALLOPROTEINASE; METHYLENE BLUE; NANOSCALE ULTRASOUND CONTRAST AGENT; PERFLUOROBUTANE NANODROPLET; PERFLUOROCARBON NANODROPLET; THYMOCYTE DIFFERENTIATION ANTIGEN 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; DIAGNOSTIC AGENT; NANOPARTICLE;

ACOUSTIC IMPEDANCE; ACOUSTIC MOLECULAR IMAGING; ARTICLE; B SCAN; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CHEMICAL COMPOSITION; CONTRAST ENHANCEMENT; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ACTIVITY; HUMAN; LIGHT ABSORPTION; MICROBUBBLE; MOLECULAR IMAGING; MOLECULAR INTERACTION; NANOBIOTECHNOLOGY; NONHUMAN; PANCREAS CANCER; PARTICLE SIZE; PHOTOACOUSTIC MOLECULAR IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; THYROID CARCINOMA; TUMOR MICROENVIRONMENT; ACOUSTICS; ANIMAL; DIAGNOSTIC USE; NEOPLASMS; PHOTOACOUSTICS; PROCEDURES; METHODOLOGY; NANODROPLET; NEOPLASM; REVIEW; ULTRASOUND;

ACOUSTICS; ANIMALS; CONTRAST MEDIA; HUMANS; MOLECULAR IMAGING; NEOPLASMS; PHOTOACOUSTIC TECHNIQUES;

CANCER; MICROBUBBLE; MOLECULAR IMAGING; NANODROPLET; NANOPARTICLE; PHOTOACOUSTIC IMAGING; ULTRASOUND;

EID: 84891707932     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.115568     Document Type: Article

References (25)

1. Kiessling F, Huppert J, Palmowski M. Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem. 2009;16:627-642.
2. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol. 2010;65:567-581.
3. Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR. 2012;199:292-299.
4. Dietrich CF, Averkiou MA, Correas J-M, Lassau N, Leen E, Piscaglia F. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33:344-351.
5. Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A. Dynamic contrastenhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment. Target Oncol. 2010;5:53-58.
6. Anderson CR, Hu X, Zhang H, et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol. 2011;46:215-224.
7. Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45:89-95.
8. Sugimoto K, Moriyasu F, Negishi Y, et al. Quantification in molecular ultrasound imaging a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft. J Ultrasound Med. 2012;31: 1909-1916.
9. Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology. 2010;256:519-527.
10. Bzyl J, Palmowski M, Rix A, et al. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol. 2013;23:468-475.
11. Bachawal SV, Jensen KC, Lutz AM, et al. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res. 2013;73:1689-1698.
12. Kaneko OF, Willmann JK. Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg. 2012;2:87-97.
13. Foygel K, Wang H, Machtaler S, et al. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology. 2013;145:885-894.
14. Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect (EPR) for nanomedicine drug delivery in oncology. Cancer Res. 2013;73:2412-2417.
15. Wilson K, Homan K, Emelianov S. Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat Commun. 2012;3:618.
16. Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4:492-510.
17. Williams R, Wright C, Cherin E, et al. Characterization of ubmicron phasechange perfluorocarbon droplets for extravascular ultrasound imaging of cancer. Ultrasound Med Biol. 2013;39:475-489.
18. Luke GP, Yeager D, Emelianov SY. Biomedical applications of photoacoustic imaging with exogenous contrast agents. Ann Biomed Eng. 2012;40:422-437.
19. Mallidi S, Luke GP, Emelianov S. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011;29:213-221.
20. Beard P. Biomedical photoacoustic imaging. Interface Focus. 2011;1:602-631.
21. de la Zerda A, Liu Z, Bodapati S, et al. Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice. Nano Lett. 2010;10:2168-2172.
22. Levi J, Kothapalli S-R, Bohndiek S, et al. Molecular photoacoustic imaging of follicular thyroid carcinoma. Clin Cancer Res. 2013;19:1494-1502.
23. Shao Q, Morgounova E, Jiang C, Choi J, Bischof J, Ashkenazi S. In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals. J Biomed Opt. 2013;18:076019.
24. Chen Y-S, Frey W, Kim S, Kruizinga P, Homan K, Emelianov S. Silica-coated gold nanorods as photoacoustic signal nanoamplifiers. Nano Lett. 2011;11:348-354.
25. Truby RL, Emelianov SY, Homan KA. Ligand-mediated self-assembly of hybrid plasmonic and superparamagnetic nanostructures. Langmuir. 2013;29:2465-2470.